发明名称 |
Controlled release sterile injectable aripiprazole formulation comprising a particulate aripiprazole having a mean particle size of 1-10 microns, administered once or twice a month and comprising a freeze-dried formulation, method of their production and uses thereof in treating schizophrenia |
摘要 |
<p>A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle thereof, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.</p> |
申请公布号 |
IL175072(A) |
申请公布日期 |
2015.06.30 |
申请号 |
IL20060175072 |
申请日期 |
2006.04.20 |
申请人 |
OTSUKA PHARMACEUTICAL CO. LTD. |
发明人 |
|
分类号 |
A61K;A61K9/19;A61K31/496;A61K47/26;A61K47/38;A61P |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|